Bard Bearish Signs

Hewlett Packard (HPQ)

Dell (DELL)

Facebook (FB)

Apple (AAPL)

Goldman Sachs (GS)

Fred's First Quarter 2012 EPS Increase 17%

Newell Rubbermaid to Reaffirm Fiscal Year 2012 Outlook

Best ETFs For Facebook Exposure

McDonald's Announces Quarterly Cash Dividend

Is KB HOME Closing in to Resistance?

Bard Bearish Signs

Published on Thursday, 09 February 2012 04:39 Written by TradersHuddle Wire

bcr New York, February 9th (TradersHuddle.com) - Shares of C. R. Bard, Inc. (NYSE:BCR) ended the trading session lower by $0.29 or -0.31% from its previous close. Bard's price action formed what is considered to be a bearish engulfing candlestick chart pattern.

C. R. Bard, Inc. (NYSE:BCR) designs, manufactures, distributes, and sells medical, surgical, diagnostic, and patient care devices. The Company sells a broad range of products worldwide to hospitals, individual healthcare professionals, and extended care facilities. Bard markets vascular, urological, oncological, and surgical specialties products.

Bard's current stock range is defined by calculated support defined at $82.22 and by the resistance level at $94.12, which should be used by traders planning their trades.

Traders wanting to establish a position in Bard stock need to pay close attention at the bearish engulfing pattern, since it could mark a trend reversal to current Bard shares price action. The Bearish engulfing pattern is a leading warning sign, therefore traders should closely monitor price action for indications of a trend reversal. Below an Engulfing Bearish Candle Illustration:

Note - Automated Content Created By TradersHuddle's Technical Scanner

Bard Names Christopher S. Holland Senior Vice President and CFO - Benzinga
C.R. Bard Stock To Go Ex-dividend Tomorrow (BCR) - TheStreet.com
18 Dividend Stocks That Will Outlive the Hype - TheStreet.com
Morgan Keegan: C.R. Bard's Stent Approval to Have Manageable Impact - Benzinga
Bank of America's Takeaways from Meeting with C R Bard's Senior Management - Benzinga
C.R. Bard Rises On Unusually High Volume (BCR) - TheStreet.com
Notable Call Options Activity in C. R. Bard - Benzinga
Jefferies & Company Raises PT on CR Bard from $94 to $104 - Benzinga
Citigroup Raises PT on CR Bard to $95 - Benzinga
UPDATE: Jefferies Increases C.R. Bard's PT from $94 to $104 - Benzinga

Volatile market? That's when profit potential skyrockets for options traders. Now you can get up to 50 trade opportunities a week from top options experts -- plus much more -- on our exciting new site OptionsProfits. Try it FREE!